Capula Management’s Bristol-Myers Squibb BMY Stock Holding History

Capula Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$570K	Buy	+9,400	New	+$548K	﹤0.01%	484
2025 Q4	–	Sell	-4,000	Closed	-$180K	–	834
2025 Q3	$180K	Buy	4,000 +1,300	+48%	+$60.7K	﹤0.01%	633
2025 Q2	$125K	Buy	+2,700	New	+$133K	﹤0.01%	472
2023 Q3	–	Sell	-200,000	Closed	-$12.8M	–	520
2023 Q2	$12.8M	Buy	200,000 +77,600	+63%	+$5.2M	0.31%	43
2023 Q1	$8.48M	Sell	122,400 -138,600	-53%	-$9.78M	0.1%	172
2022 Q4	$18.8M	Sell	261,000 -377,900	-59%	-$28.5M	0.25%	105
2022 Q3	$45.4M	Sell	638,900 -409,100	-39%	-$29.7M	0.61%	32
2022 Q2	$80.7M	Buy	1,048,000 +448,000	+75%	+$34.1M	1.38%	10
2022 Q1	$43.8M	Buy	+600,000	New	+$40.3M	0.63%	40
2021 Q4	–	Sell	-84,200	Closed	-$4.98M	–	259
2021 Q3	$4.98M	Buy	+84,200	New	+$5.55M	0.06%	238
2021 Q2	–	Sell	-33,000	Closed	-$2.08M	–	770
2021 Q1	$2.08M	Sell	33,000 -127,000	-79%	-$7.9M	0.04%	291
2020 Q4	$9.93M	Buy	160,000 +151,800	+1,851%	+$9.33M	0.49%	50
2020 Q3	$494K	Hold	8,200	–	–	0.06%	115
2020 Q2	$482K	Sell	8,200 -551,800	-99%	-$33M	0.02%	281
2020 Q1	$31.2M	Buy	560,000 +525,000	+1,500%	+$32.1M	1.13%	12
2019 Q4	$2.25M	Buy	+35,000	New	+$2M	0.05%	245

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's BMY Position: Q1 2026 in Review

Capula Management reduced its Bristol-Myers Squibb (BMY) stake by 72% in Q1 2026, selling an estimated $623K and leaving 4,113 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Capula Management first reported a position in BMY in Q1 2020 and has held it in 16 quarters since. The position peaked at $16.2M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capula Management held 4,113 shares of Bristol-Myers Squibb worth $249K as of Q1 2026.
Capula Management sold 10,682 Bristol-Myers Squibb shares in Q1 2026, an estimated $623K.
Bristol-Myers Squibb made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #689 holding.
Capula Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 16 quarters since.
Capula Management's Bristol-Myers Squibb position peaked at $16.2M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.